(Q33288333)

25 July 2017

title

Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program (English)

1 reference

25 July 2017

1 reference

1 reference

1 reference

Masahiro Satake

1

1 reference

25 July 2017

Rikizo Taira

2

1 reference

25 July 2017

Hisao Yugi

3

1 reference

25 July 2017

Satoru Hino

4

1 reference

25 July 2017

Kimihiro Kanemitsu

5

1 reference

25 July 2017

Hisami Ikeda

6

1 reference

25 July 2017

Kenji Tadokoro

7

1 reference

25 July 2017

publication date

1 July 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

47

1 reference

25 July 2017

issue

7

1 reference

25 July 2017

page(s)

1197-1205

1 reference

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Infectious risks associated with the transfusion of blood components and pathogen inactivation in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Economics of pathogen inactivation technology for platelet concentrates in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

HCV and HIV-1 donor screening using nucleic acid amplification technique (NAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Detection and significance of anti-HBc in the blood bank; preliminary results of a controlled prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

An assay for the detection of the DNA genome of hepatitis B virus in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Quantification of hepatitis B virus genomes and infectivity in human serum samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Occult hepatitis B virus infection and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Sequence analysis of hepatitis B virus DNA in immunologically negative infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Low-level secretion of human hepatitis B virus virions caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Hepatitis B virus harboring nucleotide deletions in the core promoter region and genotype B correlate with low viral replication activity in anti-HBe positive carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Long-term histologic and virologic outcomes of acute self-limited hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Occult hepatitis B virus infection: implications in transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01276.X

10.1111/J.1537-2995.2007.01276.X

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference